📊 Score Breakdown
Offering Ability
20
Cash Runway
10
Float Risk
40
Warrant Exposure
50
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
32%
🔄 Reverse Split
55%
• 50-day avg $0.01 below $1 exchange minimum
📜 Warrant Exercise
15%
• Warrant overhang: 10.7% of shares outstanding
💹 Market Data
Market Cap$701.9K
Shares Outstanding70.19M
FloatN/A
Cash$28.08M
Debt$619.2K
Short InterestN/A
🏛 Institutional Holdings
Institutional data not yet available.
📉 Short Interest
Short Interest1.6K
Days to Cover1.0
% of FloatN/A
FINRA data as of Apr 30, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Dec 31, 2025
xbrl
XBRL WARRANT
Dec 31, 2023
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for EMMA
📊 EMMA FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 EMMA Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.